MedTrace Logo

Hypertonic Saline for Outpatient Bronchiolitis

NCT00696540 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2008-06-12

No results posted yet for this study

Summary

We will study if small children who become ill with respiratory distress during the RSV epidemic are better relieved with salbutamol nebulizations diluted in hypertonic (3%), instead of normal (0.9%) saline.

Conditions

  • Bronchiolitis
  • Respiratory Distress

Interventions

DRUG

Inhalation of salbutamol diluted in hypertonic saline

The first of 3 nebulizations of 0.5 mg of Salbutamol is diluted in 3.5 ml of hypertonic (3%) saline. The second and the third are diluted in normal (0.9%) saline.

DRUG

Inhalation of salbutamol diluted in normal saline

The 3 nebulizations of 0.5 mg of Salbutamol are diluted in 3.5 ml of normal (0.9%) saline.

Sponsors & Collaborators

  • Clínica Vespucio, Santiago, Chile

    collaborator UNKNOWN

  • University Diego Portales

    lead OTHER

Principal Investigators

  • Irmeli Roine, MD, PhD · University Diego Portales

  • Ricardo Mercado, MD · Clinica Vespucio, Santiago, Chile

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
24 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-09-30
Completion
2008-10-31

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00696540 on ClinicalTrials.gov